ACG | Age 51 | Age 101 | Age 151 |
---|---|---|---|
Non-user | 68 (22.6%) | 119 (28.7%) | 78 (17.9%) |
No diagnoses | 19 (6.3%) | 77 (18.6%) | 99 (22.8%) |
Acute minor | 62 (20.6%) | 67 (16.2%) | 67 (15.4%) |
Acute minor and likely to recur (with or without allergies) | 58 (19.3%) | 26 (6.3%) | 23 (5.3%) |
Likely to recur (with or without allergies) | 29 (9.6%) | 38 (9.2%) | 46 (10.6%) |
Acute minor and major | 13 (4.3%) | 18 (4.4%) | 9 (2.1%) |
Acute major | 6 (2.0%) | 11 (2.7%) | 24 (5.5%) |
2–3 other ADGs | 16 (5.3%) | 16 (3.9%) | 29 (6.7%) |
Other ACGs | 30 (10.0%) | 42 (10.1%) | 60 (13.8%) |
301 | 414 | 435 | |
Resource Utilisation Band | |||
Non-user | 68 (22.6%) | 119 (28.7%) | 78 (17.9%) |
Healthy user2 | 87 (28.9%) | 150 (36.2%) | 177 (40.7%) |
Low morbidity2 | 124 (41.2%) | 131 (31.6%) | 151 (34.7%) |
Moderate morbidity2 | 22 (7.3%) | 14 (3.4%) | 28 (6.4%) |
High morbidity2 | 0 | 0 | 1 (0.2%) |
Very high morbidity2 | 0 | 0 | 0 |
301 | 414 | 435 |